- Home
- NSP vs PTGX Comparison
NSP vs PTGX Comparison
Compare NSP & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSP
- PTGX
- Stock Information
- Founded
- NSP 1986
- PTGX 2006
- Country
- NSP United States
- PTGX United States
- Employees
- NSP N/A
- PTGX N/A
- Industry
- NSP Professional Services
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- NSP Consumer Discretionary
- PTGX Health Care
- Exchange
- NSP Nasdaq
- PTGX Nasdaq
- Market Cap
- NSP 2.6B
- PTGX 2.4B
- IPO Year
- NSP 1997
- PTGX 2016
- Fundamental
- Price
- NSP $89.22
- PTGX $48.36
- Analyst Decision
- NSP Hold
- PTGX Strong Buy
- Analyst Count
- NSP 4
- PTGX 8
- Target Price
- NSP $95.67
- PTGX $66.50
- AVG Volume (30 Days)
- NSP 561.5K
- PTGX 1.6M
- Earning Date
- NSP 04-30-2025
- PTGX 05-06-2025
- Dividend Yield
- NSP 2.67%
- PTGX N/A
- EPS Growth
- NSP N/A
- PTGX N/A
- EPS
- NSP 2.39
- PTGX 4.23
- Revenue
- NSP $6,581,000,000.00
- PTGX $434,433,000.00
- Revenue This Year
- NSP $5.91
- PTGX N/A
- Revenue Next Year
- NSP $7.79
- PTGX $8.12
- P/E Ratio
- NSP $37.62
- PTGX $11.43
- Revenue Growth
- NSP 1.47
- PTGX 624.05
- 52 Week Low
- NSP $68.79
- PTGX $24.22
- 52 Week High
- NSP $109.80
- PTGX $60.60
- Technical
- Relative Strength Index (RSI)
- NSP 54.58
- PTGX 51.52
- Support Level
- NSP $87.49
- PTGX $51.06
- Resistance Level
- NSP $90.61
- PTGX $53.70
- Average True Range (ATR)
- NSP 2.73
- PTGX 2.27
- MACD
- NSP -0.31
- PTGX -0.94
- Stochastic Oscillator
- NSP 73.01
- PTGX 9.41
About NSP Insperity Inc.
Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.